Roxanne Keynejad summarises the ESMI-II study on community perinatal mental health teams and mental health, obstetric and neonatal outcomes in pregnant women.
[read the full story...]
Andrea Cipriani is back, this time writing with Rosario Aronica to summarise an individual patient data meta-analysis on the use of psychological interventions for preventing relapse in depression.
[read the full story...]
Samei Huda summarises a new network meta-analysis in the Lancet Psychiatry on the efficacy and effectiveness of antipsychotics for schizophrenia in research settings, such as randomised controlled trials, versus real-world and clinical settings.
[read the full story...]
Joe Pierre reports on the first published study exploring the relationship between antipsychotic dose and risk of relapse in first episode schizophrenia, which suggests that standard antipsychotic dosing is best for relapse prevention.
[read the full story...]
Raphael Rifkin-Zybutz and Sameer Jauhar summarise the recently published ANTLER trial, which explores whether antidepressant maintenance can reduce the risk of relapse in depression.
[read the full story...]
Jessica Scaife reviews a individual patient data meta-analysis exploring the continuation of antidepressants versus sequential psychological interventions to prevent relapse in depression.
[read the full story...]
Joseph Pierre appraises a recent meta-analysis on long-acting injectable antipsychotics compared to oral antipsychotic medication for the maintenance treatment of schizophrenia.
[read the full story...]
A group of UCL Mental Health MSc students summarise a recent pilot study, which explores the acceptability and feasibility of the Texting for Relapse Prevention (T4RP) programme for people with schizophrenia or schizoaffective disorder.
[read the full story...]
Lucy Purnell summarises a recent systematic review which finds little support for parental involvement in cognitive behavioural therapy for adolescent anxiety disorders.
[read the full story...]
In her debut blog, Rosa Pitts summarises the ARIES trial, which suggests it may be feasible to use a smartphone app (My Journey 3) to help prevent relapse in psychosis, although questions remain about long-term participant engagement with the app.
[read the full story...]
